{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:00:05Z","timestamp":1786708805114,"version":"build-2736575974"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KI20239B"],"award-info":[{"award-number":["01KI20239B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FKZ 01ZZ2015"],"award-info":[{"award-number":["FKZ 01ZZ2015"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KI20198A"],"award-info":[{"award-number":["01KI20198A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["416072091"],"award-info":[{"award-number":["416072091"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 850 (Subprojects C9 and Z1)"],"award-info":[{"award-number":["SFB 850 (Subprojects C9 and Z1)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1479 (441891347- S1)"],"award-info":[{"award-number":["SFB 1479 (441891347- S1)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1160 (Project Z02)"],"award-info":[{"award-number":["SFB 1160 (Project Z02)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1453 (431984000 - S1)"],"award-info":[{"award-number":["SFB 1453 (431984000 - S1)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR167 (Project Z01)"],"award-info":[{"award-number":["TRR167 (Project Z01)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["415089553"],"award-info":[{"award-number":["415089553"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1129 (240245660)"],"award-info":[{"award-number":["SFB 1129 (240245660)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 186 (278001972)"],"award-info":[{"award-number":["TRR 186 (278001972)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 179 (272983813)"],"award-info":[{"award-number":["TRR 179 (272983813)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WI 5171\/1-1"],"award-info":[{"award-number":["WI 5171\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FU 436\/20-1"],"award-info":[{"award-number":["FU 436\/20-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1177 (259130777)"],"award-info":[{"award-number":["SFB 1177 (259130777)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70113680"],"award-info":[{"award-number":["70113680"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pattern recognition receptors (PRRs) and interferons (IFNs) serve as essential antiviral defense against SARS-CoV-2, the causative agent of the COVID-19 pandemic. Type III IFNs (IFN-\u03bb) exhibit cell-type specific and long-lasting functions in auto-inflammation, tumorigenesis, and antiviral defense. Here, we identify the deubiquitinating enzyme USP22 as central regulator of basal IFN-\u03bb secretion and SARS-CoV-2 infections in human intestinal epithelial cells (hIECs). USP22-deficient hIECs strongly upregulate genes involved in IFN signaling and viral defense, including numerous IFN-stimulated genes (ISGs), with increased secretion of IFN-\u03bb and enhanced STAT1 signaling, even in the absence of exogenous IFNs or viral infection. Interestingly, USP22 controls basal and 2\u20323\u2032-cGAMP-induced STING activation and loss of STING reversed STAT activation and ISG and IFN-\u03bb expression. Intriguingly, USP22-deficient hIECs are protected against SARS-CoV-2 infection, viral replication, and the formation of de novo infectious particles, in a STING-dependent manner. These findings reveal USP22 as central host regulator of STING and type III IFN signaling, with important implications for SARS-CoV-2 infection and antiviral defense.<\/jats:p>","DOI":"10.1038\/s41419-022-05124-w","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T02:03:59Z","timestamp":1659751439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5290-9468","authenticated-orcid":false,"given":"Rebekka","family":"Karlowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Stanifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Roedig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Andrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisa","family":"Bojkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bechtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kowald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Boerries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6744-2087","authenticated-orcid":false,"suffix":"Jr.","given":"Jindrich","family":"Cinatl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steeve","family":"Boulant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6532-7651","authenticated-orcid":false,"given":"Sjoerd J. L.","family":"van Wijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"key":"5124_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805\u201320.","journal-title":"Cell"},{"key":"5124_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","volume":"6","author":"D Li","year":"2021","unstructured":"Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther. 2021;6:291.","journal-title":"Signal Transduct Target Ther"},{"key":"5124_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.immuni.2007.08.012","volume":"27","author":"A Pichlmair","year":"2007","unstructured":"Pichlmair A, Reis e Sousa C. Innate recognition of viruses. Immunity 2007;27:370\u201383.","journal-title":"Immunity"},{"key":"5124_CR4","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1084\/jem.20080091","volume":"205","author":"H Kato","year":"2008","unstructured":"Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K, et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med. 2008;205:1601\u201310.","journal-title":"J Exp Med"},{"key":"5124_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021;21:548\u201369.","journal-title":"Nat Rev Immunol"},{"key":"5124_CR6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41564-019-0421-x","volume":"4","author":"EV Mesev","year":"2019","unstructured":"Mesev EV, LeDesma RA, Ploss A. Decoding type I and III interferon signalling during viral infection. Nat Microbiol. 2019;4:914\u201324.","journal-title":"Nat Microbiol"},{"key":"5124_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","volume":"50","author":"HM Lazear","year":"2019","unstructured":"Lazear HM, Schoggins JW, Diamond MS. Shared and distinct functions of Type I and Type III interferons. Immunity 2019;50:907\u201323.","journal-title":"Immunity"},{"key":"5124_CR8","doi-asserted-by":"publisher","first-page":"101303","DOI":"10.1016\/j.smim.2019.101303","volume":"43","author":"SV Kotenko","year":"2019","unstructured":"Kotenko SV, Rivera A, Parker D, Durbin JE. Type III IFNs: Beyond antiviral protection. Semin Immunol. 2019;43:101303.","journal-title":"Semin Immunol"},{"key":"5124_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","volume":"1","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Rice CM. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol. 2011;1:519\u201325.","journal-title":"Curr Opin Virol"},{"key":"5124_CR10","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","volume":"27","author":"A Park","year":"2020","unstructured":"Park A, Iwasaki A. Type I and Type III interferons\u2014induction, signaling, evasion, and application to combat COVID-19. Cell Host Microbe. 2020;27:870\u20138.","journal-title":"Cell Host Microbe"},{"key":"5124_CR11","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41577-019-0182-z","volume":"19","author":"L Ye","year":"2019","unstructured":"Ye L, Schnepf D, Staeheli P. Interferon-lambda orchestrates innate and adaptive mucosal immune responses. Nat Rev Immunol. 2019;19:614\u201325.","journal-title":"Nat Rev Immunol"},{"key":"5124_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.immuni.2019.07.007","volume":"51","author":"A Forero","year":"2019","unstructured":"Forero A, Ozarkar S, Li H, Lee CH, Hemann EA, Nadjsombati MS, et al. Differential activation of the transcription factor IRF1 underlies the distinct immune responses elicited by Type I and Type III interferons. Immunity 2019;51:451\u201364 e6.","journal-title":"Immunity"},{"key":"5124_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2017.04.025","volume":"46","author":"IE Galani","year":"2017","unstructured":"Galani IE, Triantafyllia V, Eleminiadou EE, Koltsida O, Stavropoulos A, Manioudaki M, et al. Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness. Immunity 2017;46:875\u201390 e6.","journal-title":"Immunity"},{"key":"5124_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-micro-020518-115759","volume":"73","author":"TS Fung","year":"2019","unstructured":"Fung TS, Liu DX. Human Coronavirus: host-pathogen interaction. Annu Rev Microbiol. 2019;73:529\u201357.","journal-title":"Annu Rev Microbiol"},{"key":"5124_CR15","doi-asserted-by":"publisher","first-page":"45.","DOI":"10.1038\/s42003-021-02983-5","volume":"5","author":"CJ Neufeldt","year":"2022","unstructured":"Neufeldt CJ, Cerikan B, Cortese M, Frankish J, Lee J-Y, Plociennikowska A, et al. SARS-CoV-2 infection induces a proinflammatory cytokine response through cGAS-STING and NF-\u03baB. Commun Biol. 2022;5:45.","journal-title":"Commun Biol"},{"key":"5124_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation, and intervention. Nat Rev Immunol. 2020;20:363\u201374.","journal-title":"Nat Rev Immunol"},{"key":"5124_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","volume":"14","author":"LB Ivashkiv","year":"2014","unstructured":"Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14:36\u201349.","journal-title":"Nat Rev Immunol"},{"key":"5124_CR18","doi-asserted-by":"publisher","first-page":"107863","DOI":"10.1016\/j.celrep.2020.107863","volume":"32","author":"ML Stanifer","year":"2020","unstructured":"Stanifer ML, Kee C, Cortese M, Zumaran CM, Triana S, Mukenhirn M, et al. Critical role of Type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells. Cell Rep. 2020;32:107863.","journal-title":"Cell Rep"},{"key":"5124_CR19","doi-asserted-by":"publisher","first-page":"e10232","DOI":"10.15252\/msb.202110232","volume":"17","author":"S Triana","year":"2021","unstructured":"Triana S, Metz-Zumaran C, Ramirez C, Kee C, Doldan P, Shahraz M, et al. Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut. Mol Syst Biol. 2021;17:e10232.","journal-title":"Mol Syst Biol"},{"key":"5124_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0960-9822(98)70086-7","volume":"8","author":"L Erlandsson","year":"1998","unstructured":"Erlandsson L, Blumenthal R, Eloranta ML, Engel H, Alm G, Weiss S, et al. Interferon-beta is required for interferon-alpha production in mouse fibroblasts. Curr Biol. 1998;8:223\u20136.","journal-title":"Curr Biol"},{"key":"5124_CR21","doi-asserted-by":"publisher","first-page":"e1000193","DOI":"10.1371\/journal.ppat.1000193","volume":"4","author":"H Phipps-Yonas","year":"2008","unstructured":"Phipps-Yonas H, Seto J, Sealfon SC, Moran TM, Fernandez-Sesma A. Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus. PLoS Pathog. 2008;4:e1000193.","journal-title":"PLoS Pathog"},{"key":"5124_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1128\/jvi.7.6.792-801.1971","volume":"7","author":"WE Stewart 2nd","year":"1971","unstructured":"Stewart WE 2nd, Gosser LB, Lockart RZ Jr. Priming: a nonantiviral function of interferon. J Virol. 1971;7:792\u2013801.","journal-title":"J Virol"},{"key":"5124_CR23","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1099\/vir.0.013599-0","volume":"90","author":"T Kuri","year":"2009","unstructured":"Kuri T, Zhang X, Habjan M, Mart\u00ednez-Sobrido L, Garc\u00eda-Sastre A, Yuan Z, et al. Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation. J Gen Virol. 2009;90:2686\u201394. Pt 11","journal-title":"J Gen Virol"},{"key":"5124_CR24","doi-asserted-by":"publisher","first-page":"13958","DOI":"10.1074\/jbc.AC120.013788","volume":"295","author":"U Felgenhauer","year":"2020","unstructured":"Felgenhauer U, Schoen A, Gad HH, Hartmann R, Schaubmar AR, Failing K, et al. Inhibition of SARS-CoV-2 by type I and type III interferons. J Biol Chem. 2020;295:13958\u201364.","journal-title":"J Biol Chem"},{"key":"5124_CR25","doi-asserted-by":"publisher","first-page":"608645","DOI":"10.3389\/fimmu.2020.608645","volume":"11","author":"ML Stanifer","year":"2020","unstructured":"Stanifer ML, Guo C, Doldan P, Boulant S. Importance of Type I and III interferons at respiratory and intestinal barrier surfaces. Front Immunol. 2020;11:608645.","journal-title":"Front Immunol"},{"key":"5124_CR26","doi-asserted-by":"publisher","first-page":"e00985","DOI":"10.1128\/JVI.00985-20","volume":"94","author":"A Vanderheiden","year":"2020","unstructured":"Vanderheiden A, Ralfs P, Chirkova T, Upadhyay AA, Zimmerman MG, Bedoya S, et al. Type I and Type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures. J Virol. 2020;94:e00985\u201320.","journal-title":"J Virol"},{"key":"5124_CR27","doi-asserted-by":"publisher","first-page":"e01928","DOI":"10.1128\/mBio.01928-20","volume":"11","author":"I Busnadiego","year":"2020","unstructured":"Busnadiego I, Fernbach S, Pohl MO, Karakus U, Huber M, Trkola A, et al. Antiviral Activity of Type I, II, and III interferons counterbalances ACE2 inducibility and restricts SARS-CoV-2. mBio. 2020;11:e01928\u201320.","journal-title":"mBio"},{"key":"5124_CR28","doi-asserted-by":"publisher","first-page":"e105912","DOI":"10.15252\/embj.2020105912","volume":"40","author":"MM Lamers","year":"2021","unstructured":"Lamers MM, van der Vaart J, Knoops K, Riesebosch S, Breugem TI, Mykytyn AZ, et al. An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells. EMBO J. 2021;40:e105912.","journal-title":"EMBO J"},{"key":"5124_CR29","doi-asserted-by":"publisher","first-page":"105015","DOI":"10.1016\/j.antiviral.2021.105015","volume":"187","author":"Q Zhu","year":"2021","unstructured":"Zhu Q, Zhang Y, Wang L, Yao X, Wu D, Cheng J, et al. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system. Antivir Res. 2021;187:105015.","journal-title":"Antivir Res"},{"key":"5124_CR30","doi-asserted-by":"publisher","first-page":"e00490","DOI":"10.1128\/JVI.00490-21","volume":"95","author":"W Liu","year":"2021","unstructured":"Liu W, Reyes HM, Yang JF, Li Y, Stewart KM, Basil MC, et al. Activation of STING signaling pathway effectively blocks human coronavirus infection. J Virol. 2021;95:e00490\u201321.","journal-title":"J Virol"},{"key":"5124_CR31","doi-asserted-by":"publisher","first-page":"eabi9007","DOI":"10.1126\/sciimmunol.abi9007","volume":"6","author":"M Li","year":"2021","unstructured":"Li M, Ferretti M, Ying B, Descamps H, Lee E, Dittmar M, et al. Pharmacological activation of STING blocks SARS-CoV-2 infection. Sci Immunol. 2021;6:eabi9007.","journal-title":"Sci Immunol"},{"key":"5124_CR32","doi-asserted-by":"publisher","first-page":"eabi9002","DOI":"10.1126\/sciimmunol.abi9002","volume":"6","author":"F Humphries","year":"2021","unstructured":"Humphries F, Shmuel-Galia L, Jiang Z, Wilson R, Landis P, Ng S-L, et al. A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. Sci Immunol. 2021;6:eabi9002.","journal-title":"Sci Immunol"},{"key":"5124_CR33","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1126\/science.abc3545","volume":"369","author":"A Broggi","year":"2020","unstructured":"Broggi A, Ghosh S, Sposito B, Spreafico R, Balzarini F, Lo Cascio A, et al. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science 2020;369:706\u201312.","journal-title":"Science"},{"key":"5124_CR34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.abc2061","volume":"369","author":"J Major","year":"2020","unstructured":"Major J, Crotta S, Llorian M, McCabe TM, Gad HH, Priestnall SL, et al. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. Science 2020;369:712\u20137.","journal-title":"Science"},{"key":"5124_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.chom.2009.05.012","volume":"5","author":"MK Isaacson","year":"2009","unstructured":"Isaacson MK, Ploegh HL. Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection. Cell Host Microbe. 2009;5:559\u201370.","journal-title":"Cell Host Microbe"},{"key":"5124_CR36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fcell.2019.00392","volume":"7","author":"M van Huizen","year":"2019","unstructured":"van Huizen M, Kikkert M. The role of atypical ubiquitin chains in the regulation of the antiviral innate immune response. Front Cell Dev Biol. 2019;7:392.","journal-title":"Front Cell Dev Biol"},{"key":"5124_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.20151531","volume":"213","author":"SM Heaton","year":"2016","unstructured":"Heaton SM, Borg NA, Dixit VM. Ubiquitin in the activation and attenuation of innate antiviral immunity. J Exp Med. 2016;213:1\u201313.","journal-title":"J Exp Med"},{"key":"5124_CR38","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.immuni.2010.10.013","volume":"33","author":"T Tsuchida","year":"2010","unstructured":"Tsuchida T, Zou J, Saitoh T, Kumar H, Abe T, Matsuura Y, et al. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 2010;33:765\u201376.","journal-title":"Immunity"},{"key":"5124_CR39","doi-asserted-by":"publisher","first-page":"28646","DOI":"10.1074\/jbc.M112.362608","volume":"287","author":"J Zhang","year":"2012","unstructured":"Zhang J, Hu MM, Wang YY, Shu HB. TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA\/STING protein for K63-linked ubiquitination. J Biol Chem. 2012;287:28646\u201355.","journal-title":"J Biol Chem"},{"key":"5124_CR40","doi-asserted-by":"publisher","first-page":"eaah7119.","DOI":"10.1126\/sciimmunol.aah7119","volume":"2","author":"G Ni","year":"2017","unstructured":"Ni G, Konno H, Barber GN. Ubiquitination of STING at lysine 224 controls IRF3 activation. Sci Immunol. 2017;2:eaah7119.","journal-title":"Sci Immunol"},{"key":"5124_CR41","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.immuni.2014.11.011","volume":"41","author":"Q Wang","year":"2014","unstructured":"Wang Q, Liu X, Cui Y, Tang Y, Chen W, Li S, et al. The E3 ubiquitin ligase AMFR and INSIG1 bridge the activation of TBK1 kinase by modifying the adaptor STING. Immunity 2014;41:919\u201333.","journal-title":"Immunity"},{"key":"5124_CR42","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.immuni.2009.01.008","volume":"30","author":"B Zhong","year":"2009","unstructured":"Zhong B, Zhang L, Lei C, Li Y, Mao AP, Yang Y, et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 2009;30:397\u2013407.","journal-title":"Immunity"},{"key":"5124_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00101-w","volume":"8","author":"J Xing","year":"2017","unstructured":"Xing J, Zhang A, Zhang H, Wang J, Li XC, Zeng M-S, et al. TRIM29 promotes DNA virus infections by inhibiting innate immune response. Nat Commun. 2017;8:945.","journal-title":"Nat Commun"},{"key":"5124_CR44","doi-asserted-by":"publisher","first-page":"e57306.","DOI":"10.7554\/eLife.57306","volume":"9","author":"EJ Fenech","year":"2020","unstructured":"Fenech EJ, Lari F, Charles PD, Fischer R, La\u00e9titia-Th\u00e9z\u00e9nas M, Bagola K, et al. Interaction mapping of endoplasmic reticulum ubiquitin ligases identifies modulators of innate immune signalling. eLife. 2020;9:e57306.","journal-title":"eLife"},{"key":"5124_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15534","volume":"8","author":"H Sun","year":"2017","unstructured":"Sun H, Zhang Q, Jing Y-Y, Zhang M, Wang H-Y, Cai Z, et al. USP13 negatively regulates antiviral responses by deubiquitinating STING. Nat Commun. 2017;8:15534.","journal-title":"Nat Commun"},{"key":"5124_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41418-020-0588-y","volume":"28","author":"J Zhang","year":"2021","unstructured":"Zhang J, Chen Y, Chen X, Zhang W, Zhao L, Weng L, et al. Deubiquitinase USP35 restrains STING-mediated interferon signaling in ovarian cancer. Cell Death Differ. 2021;28:139\u201355.","journal-title":"Cell Death Differ"},{"key":"5124_CR47","doi-asserted-by":"publisher","first-page":"e1007435","DOI":"10.1371\/journal.ppat.1007435","volume":"14","author":"L Zhang","year":"2018","unstructured":"Zhang L, Wei N, Cui Y, Hong Z, Liu X, Wang Q, et al. The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway. PLOS Pathog. 2018;14:e1007435.","journal-title":"PLOS Pathog"},{"key":"5124_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molcel.2007.12.015","volume":"29","author":"XY Zhang","year":"2008","unstructured":"Zhang XY, Varthi M, Sykes SM, Phillips C, Warzecha C, Zhu W, et al. The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. Mol Cell. 2008;29:102\u201311.","journal-title":"Mol Cell"},{"key":"5124_CR49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.molcel.2007.12.011","volume":"29","author":"Y Zhao","year":"2008","unstructured":"Zhao Y, Lang G, Ito S, Bonnet J, Metzger E, Sawatsubashi S, et al. A TFTC\/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. Mol Cell. 2008;29:92\u2013101.","journal-title":"Mol Cell"},{"key":"5124_CR50","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.4161\/cc.7.11.5962","volume":"7","author":"XY Zhang","year":"2008","unstructured":"Zhang XY, Pfeiffer HK, Thorne AW, McMahon SB. USP22, an hSAGA subunit, and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A. Cell Cycle 2008;7:1522\u20134.","journal-title":"Cell Cycle"},{"key":"5124_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2141-9","volume":"10","author":"RL Kosinsky","year":"2019","unstructured":"Kosinsky RL, Helms M, Zerche M, Wohn L, Dyas A, Prokakis E, et al. USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer. Cell Death Dis. 2019;10:911.","journal-title":"Cell Death Dis"},{"key":"5124_CR52","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41418-019-0420-8","volume":"27","author":"RL Kosinsky","year":"2020","unstructured":"Kosinsky RL, Zerche M, Saul D, Wang X, Wohn L, Wegwitz F, et al. USP22 exerts tumor-suppressive functions in colorectal cancer by decreasing mTOR activity. Cell Death Differ. 2020;27:1328\u201340.","journal-title":"Cell Death Differ"},{"key":"5124_CR53","doi-asserted-by":"publisher","first-page":"e50163","DOI":"10.15252\/embr.202050163","volume":"22","author":"J Roedig","year":"2021","unstructured":"Roedig J, Kowald L, Juretschke T, Karlowitz R, Ahangarian Abhari B, Roedig H, et al. USP22 controls necroptosis by regulating receptor-interacting protein kinase 3 ubiquitination. EMBO Rep. 2021;22:e50163.","journal-title":"EMBO Rep"},{"key":"5124_CR54","doi-asserted-by":"publisher","first-page":"e20191174.","DOI":"10.1084\/jem.20191174","volume":"217","author":"Z Cai","year":"2020","unstructured":"Cai Z, Zhang MX, Tang Z, Zhang Q, Ye J, Xiong TC, et al. USP22 promotes IRF3 nuclear translocation and antiviral responses by deubiquitinating the importin protein KPNA2. J Exp Med. 2020;217:e20191174.","journal-title":"J Exp Med"},{"key":"5124_CR55","doi-asserted-by":"publisher","first-page":"eaar2824","DOI":"10.1126\/sciadv.aar2824","volume":"4","author":"Q Liu","year":"2018","unstructured":"Liu Q, Wu Y, Qin Y, Hu J, Xie W, Qin FX, et al. Broad and diverse mechanisms used by deubiquitinase family members in regulating the type I interferon signaling pathway during antiviral responses. Sci Adv. 2018;4:eaar2824.","journal-title":"Sci Adv"},{"key":"5124_CR56","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.molcel.2016.03.030","volume":"62","author":"BS Atanassov","year":"2016","unstructured":"Atanassov BS, Mohan RD, Lan X, Kuang X, Lu Y, Lin K, et al. ATXN7L3 and ENY2 coordinate activity of multiple H2B deubiquitinases important for cellular proliferation and tumor growth. Mol Cell. 2016;62:558\u201371.","journal-title":"Mol Cell"},{"key":"5124_CR57","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.celrep.2014.03.065","volume":"7","author":"NJ Lanning","year":"2014","unstructured":"Lanning NJ, Looyenga BD, Kauffman AL, Niemi NM, Sudderth J, DeBerardinis RJ, et al. A mitochondrial RNAi screen defines cellular bioenergetic determinants and identifies an adenylate kinase as a key regulator of ATP levels. Cell Rep. 2014;7:907\u201317.","journal-title":"Cell Rep"},{"key":"5124_CR58","doi-asserted-by":"publisher","first-page":"E5399","DOI":"10.1073\/pnas.1607327113","volume":"113","author":"N Sasaki","year":"2016","unstructured":"Sasaki N, Sachs N, Wiebrands K, Ellenbroek SI, Fumagalli A, Lyubimova A, et al. Reg4+ deep crypt secretory cells function as epithelial niche for Lgr5+ stem cells in colon. Proc Natl Acad Sci USA. 2016;113:E5399\u2013407.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5124_CR59","doi-asserted-by":"crossref","unstructured":"Dietlein N, Wang X, Correa ER, Erbil B, Lipka DB, Begus-Nahrmann Y, et al. Loss of Usp22 enhances histone H2B monoubiquitination and stimulates intracellular and systemic interferon immunity. bioRxiv. 2021:2021.04.09.439190.","DOI":"10.1101\/2021.04.09.439190"},{"key":"5124_CR60","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/jcp.24917","volume":"230","author":"A Hong","year":"2015","unstructured":"Hong A, Lee JE, Chung KC. Ubiquitin-Specific Protease 22 (USP22) positively regulates RCAN1 protein levels through RCAN1 de-ubiquitination. J Cell Physiol. 2015;230:1651\u201360.","journal-title":"J Cell Physiol"},{"key":"5124_CR61","doi-asserted-by":"publisher","first-page":"BSR20180250.","DOI":"10.1042\/BSR20180250","volume":"38","author":"A Basters","year":"2018","unstructured":"Basters A, Knobeloch KP, Fritz G. USP18\u2014a multifunctional component in the interferon response. Biosci Rep. 2018;38:BSR20180250.","journal-title":"Biosci Rep"},{"key":"5124_CR62","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.immuni.2012.01.011","volume":"36","author":"DJ Gough","year":"2012","unstructured":"Gough DJ, Messina NL, Clarke CJP, Johnstone RW, Levy DE. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 2012;36:166\u201374.","journal-title":"Immunity"},{"key":"5124_CR63","doi-asserted-by":"publisher","first-page":"9373","DOI":"10.1073\/pnas.0903487106","volume":"106","author":"H Cheon","year":"2009","unstructured":"Cheon H, Stark GR. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc Natl Acad Sci USA. 2009;106:9373\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5124_CR64","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ni875","volume":"4","author":"SV Kotenko","year":"2003","unstructured":"Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 2003;4:69\u201377.","journal-title":"Nat Immunol"},{"key":"5124_CR65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ni873","volume":"4","author":"P Sheppard","year":"2003","unstructured":"Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol. 2003;4:63\u20138.","journal-title":"Nat Immunol"},{"key":"5124_CR66","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.4049\/jimmunol.1100040","volume":"187","author":"S Brzostek-Racine","year":"2011","unstructured":"Brzostek-Racine S, Gordon C, Van Scoy S, Reich NC. The DNA damage response induces IFN. J Immunol. 2011;187:5336\u201345.","journal-title":"J Immunol"},{"key":"5124_CR67","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.celrep.2016.04.041","volume":"15","author":"S Ramachandran","year":"2016","unstructured":"Ramachandran S, Haddad D, Li C, Le MX, Ling AK, So CC, et al. The SAGA Deubiquitination Module Promotes DNA Repair and Class Switch Recombination through ATM and DNAPK-Mediated gammaH2AX Formation. Cell Rep. 2016;15:1554\u201365.","journal-title":"Cell Rep"},{"key":"5124_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03455-x","volume":"9","author":"C Li","year":"2018","unstructured":"Li C, Irrazabal T, So CC, Berru M, Du L, Lam E, et al. The H2B deubiquitinase Usp22 promotes antibody class switch recombination by facilitating non-homologous end joining. Nat Commun. 2018;9:1006.","journal-title":"Nat Commun"},{"key":"5124_CR69","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.immuni.2005.12.003","volume":"24","author":"DB Stetson","year":"2006","unstructured":"Stetson DB, Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006;24:93\u2013103.","journal-title":"Immunity"},{"key":"5124_CR70","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nature08476","volume":"461","author":"H Ishikawa","year":"2009","unstructured":"Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009;461:788\u201392.","journal-title":"Nature"},{"key":"5124_CR71","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.humpath.2015.04.001","volume":"46","author":"Z Wang","year":"2015","unstructured":"Wang Z, Zhu L, Guo T, Wang Y, Yang J. Decreased H2B monoubiquitination and overexpression of ubiquitin-specific protease enzyme 22 in malignant colon carcinoma. Hum Pathol. 2015;46:1006\u201314.","journal-title":"Hum Pathol"},{"key":"5124_CR72","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.cell.2007.09.046","volume":"131","author":"JS Lee","year":"2007","unstructured":"Lee JS, Shukla A, Schneider J, Swanson SK, Washburn MP, Florens L, et al. Histone crosstalk between H2B monoubiquitination and H3 methylation mediated by COMPASS. Cell 2007;131:1084\u201396.","journal-title":"Cell"},{"key":"5124_CR73","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1128\/MCB.25.2.637-651.2005","volume":"25","author":"T Xiao","year":"2005","unstructured":"Xiao T, Kao CF, Krogan NJ, Sun ZW, Greenblatt JF, Osley MA, et al. Histone H2B ubiquitylation is associated with elongating RNA polymerase II. Mol Cell Biol. 2005;25:637\u201351.","journal-title":"Mol Cell Biol"},{"key":"5124_CR74","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/ncb1712","volume":"10","author":"N Minsky","year":"2008","unstructured":"Minsky N, Shema E, Field Y, Schuster M, Segal E, Oren M. Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells. Nat Cell Biol. 2008;10:483\u20138.","journal-title":"Nat Cell Biol"},{"key":"5124_CR75","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1016\/j.molcel.2021.04.008","volume":"81","author":"L Martin-Sancho","year":"2021","unstructured":"Martin-Sancho L, Lewinski MK, Pache L, Stoneham CA, Yin X, Becker ME, et al. Functional landscape of SARS-CoV-2 cellular restriction. Mol Cell. 2021;81:2656\u201368 e8.","journal-title":"Mol Cell"},{"key":"5124_CR76","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.chom.2012.05.005","volume":"11","author":"GJ Fonseca","year":"2012","unstructured":"Fonseca GJ, Thillainadesan G, Yousef AF, Ablack JN, Mossman KL, Torchia J, et al. Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification. Cell Host Microbe. 2012;11:597\u2013606.","journal-title":"Cell Host Microbe"},{"key":"5124_CR77","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.molcel.2005.09.025","volume":"20","author":"B Zhu","year":"2005","unstructured":"Zhu B, Zheng Y, Pham AD, Mandal SS, Erdjument-Bromage H, Tempst P, et al. Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation. Mol Cell. 2005;20:601\u201311.","journal-title":"Mol Cell"},{"key":"5124_CR78","doi-asserted-by":"publisher","first-page":"e2107108118.","DOI":"10.1073\/pnas.2107108118","volume":"118","author":"S Zhang","year":"2021","unstructured":"Zhang S, Wang J, Cheng G. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1. Proc Natl Acad Sci USA. 2021;118:e2107108118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5124_CR79","doi-asserted-by":"publisher","first-page":"1445.","DOI":"10.3390\/ijms20061445","volume":"20","author":"ML Stanifer","year":"2019","unstructured":"Stanifer ML, Pervolaraki K, Boulant S. Differential Regulation of Type I and Type III Interferon Signaling. Int J Mol Sci. 2019;20:1445.","journal-title":"Int J Mol Sci"},{"key":"5124_CR80","doi-asserted-by":"publisher","first-page":"eaah5054.","DOI":"10.1126\/scisignal.aah5054","volume":"10","author":"H Sui","year":"2017","unstructured":"Sui H, Zhou M, Imamichi H, Jiao X, Sherman BT, Lane HC, et al. STING is an essential mediator of the Ku70-mediated production of IFN-\u03bb1 in response to exogenous DNA. Sci Signal. 2017;10:eaah5054.","journal-title":"Sci Signal"},{"key":"5124_CR81","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijrobp.2018.01.091","volume":"101","author":"J Chen","year":"2018","unstructured":"Chen J, Markelc B, Kaeppler J, Ogundipe VML, Cao Y, McKenna WG, et al. STING-dependent interferon-\u03bb1 induction in HT29 cells, a human colorectal cancer cell line, after gamma-radiation. Int J Radiat Oncol Biol, Phys. 2018;101:97\u2013106.","journal-title":"Int J Radiat Oncol Biol, Phys"},{"key":"5124_CR82","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41586-022-04421-w","volume":"603","author":"J Di Domizio","year":"2022","unstructured":"Di Domizio J, Gulen MF, Saidoune F, Thacker VV, Yatim A, Sharma K, et al. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature. 2022;603:145\u201351.","journal-title":"Nature"},{"key":"5124_CR83","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402\u20138.","journal-title":"Methods"},{"key":"5124_CR84","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/bioinformatics\/btq431","volume":"26","author":"BS Carvalho","year":"2010","unstructured":"Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinforma. 2010;26:2363\u20137.","journal-title":"Bioinforma"},{"key":"5124_CR85","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"5124_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-10-161","volume":"10","author":"W Luo","year":"2009","unstructured":"Luo W, Friedman MS, Shedden K, Hankenson KD, Woolf PJ. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinform. 2009;10:161.","journal-title":"BMC Bioinform"},{"key":"5124_CR87","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci"},{"key":"5124_CR88","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41421-022-00408-z","volume":"8","author":"D Bojkova","year":"2022","unstructured":"Bojkova D, Rothenburger T, Ciesek S, Wass MN, Michaelis M, Cinatl J Jr. SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment. Cell Discov. 2022;8:42.","journal-title":"Cell Discov"},{"key":"5124_CR89","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/embor.2009.192","volume":"10","author":"R Hjerpe","year":"2009","unstructured":"Hjerpe R, Aillet F, Lopitz-Otsoa F, Lang V, England P, Rodriguez MS. Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep. 2009;10:1250\u20138.","journal-title":"EMBO Rep"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05124-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05124-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05124-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T10:12:15Z","timestamp":1669284735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05124-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":89,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["5124"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05124-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.01.478628","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,6]]},"assertion":[{"value":"14 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"684"}}